Diagenic Exercises 10-for-1 Reverse Stock Split

Jun 03, 2011

NEW YORK (GenomeWeb News) – Diagenic recently announced a 10-for-1 reverse stock split, which took effect on May 30.

As a result of the split, each share of the company's stock was bumped up to NOK.50 ($.09) from NOK.05. After the split, the Norwegian firm had about 27 million shares of common stock outstanding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Featured White Papers

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

Modular DNA Assembly of PIK3CA Using Acoustic Liquid Transfer in Nanoliter Volumes

Expanded Droplet Digital PCR Multiplexing Capability Using Two Different Strategies

Decoding Carrier Screening

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Menu

Diagenic Exercises 10-for-1 Reverse Stock Split

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Translation of Dog Years Into Human Years Updated With Epigenetic Analysis

Type 2 Diabetes Associated With Altered Daily Gut Microbe Oscillations

In Brief This Week: Genomics England, Centogene, Cergentis, and More